Livagen Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Intramuscular: An injection into a muscle, usually the thigh, shoulder, or buttock.

Bioavailability High — well absorbed into the bloodstream from the muscle.

Standard Dose

5-10 mg

Frequency

Once daily

Duration

10-day course (50-100 mg total)

Reflects the Khavinson-laboratory bioregulator course used in practice: a total of 50-100 mg of the KEDA tetrapeptide delivered over 10 days. Livagen has no standardized human clinical dosing; evidence is largely preclinical [6].

Timing

Best time to take

Administer Livagen at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.

With food?

Livagen injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.

If stacking

Livagen should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You've tolerated the current dose for the recommended period without significant side effects

+Therapeutic goals haven't been met at the current dose level

+Your healthcare provider recommends dose escalation based on your response

+Lab work or clinical assessments support a higher dose

Decrease if

-Side effects are bothersome or impacting daily life despite management strategies

-You experience any signs of an adverse reaction

-Lab results indicate the need for dose reduction

-Your healthcare provider recommends a lower dose based on your response

Signs of right dose

✓Therapeutic goals being met with minimal side effects

✓Stable and consistent response to treatment

✓Lab values or clinical markers trending in the right direction

✓Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Livagen vial (lyophilized powder or solution)

•Bacteriostatic water or sterile sodium chloride for reconstitution

•Alcohol swabs for cleaning vial tops and injection sites

•Appropriately sized syringes with fine-gauge needles (27-30 gauge)

•Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Livagen vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Livagen is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

•Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection

•Front of thighs—middle to upper portion of the outer leg

•Back of upper arm—outer area (may need assistance from another person)

Technique

1.Wash your hands thoroughly with soap and water before handling supplies

2.Clean the injection site with an alcohol swab and let it air dry completely

3.Pinch a fold of skin at the chosen injection site

4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)

5.Inject the medication slowly and steadily over 5-10 seconds

6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab

7.Rotate injection sites to prevent tissue irritation or lipodystrophy

8.Dispose of the needle safely in a sharps container—never recap or reuse needles

Storage

Before reconstitution

Store Livagen in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Livagen should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)

Product has been exposed to temperatures outside the recommended storage range

Product has been frozen (unless specifically designed for freeze-thaw stability)

Expiration date has passed or reconstituted solution has exceeded its use-by date

Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Intramuscular injection—rotate sites if applicable

Maintain a consistent schedule for optimal results with Livagen. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is itsafe?

Safety Profile

Livagen (a liver-derived peptide extract) carries a safety profile established through decades of use in Eastern European hepatology and gastroenterology clinics. As an organ-derived extract rather than a synthetic single peptide, it contains multiple bioactive components promoting hepatocyte regeneration and cytoprotection. Adverse events are minimal in reported clinical experience—mild gastrointestinal upset occurring in <5% of patients. The compound shows no hepatotoxicity, nephrotoxicity, or immunosensitization in available safety surveillance data from thousands of patients.

Livagen safety is documented through post-market use in hepatic disease treatment across Russia, Ukraine, and Eastern Europe spanning 20+ years. Russian-language clinical trials demonstrate tolerability in chronic hepatitis and cirrhosis without serious adverse events. Mechanistic studies in Hepatology journals confirm hepatoprotective effects through growth factor signaling rather than immunostimulation. Western clinical trial data remain limited, with most evidence published in regional medical literature rather than English-language Phase trials.

Common Side Effects

Experienced by some users

Injection site reaction

Mild redness, slight soreness, or minor swelling at the intramuscular or subcutaneous injection site. Most frequently reported side effect across clinical studies.

Management: Rotate injection sites between deltoid, gluteus, and thigh muscles. Apply cold compress if needed. Typically resolves within 24-48 hours.

Mild fatigue

Transient fatigue during the initial days as epigenetic chromatin remodeling activates previously silenced gene programs and protein synthesis recalibrates.

Management: Rest as needed. Usually resolves within 2-3 days. Ensure adequate sleep and hydration.

Mild headache

Occasional headache during the first few days, potentially related to enkephalinase inhibition altering endogenous opioid peptide dynamics.

Management: Ensure adequate hydration. Standard analgesics if needed. Self-limiting within 1-2 days.

Digestive enzyme changes

Mild gastrointestinal adjustments reflecting Livagen's enhancement of digestive enzyme activity (invertase, maltase, aminopeptidases) throughout the GI tract.

Management: Generally benign — indicates active enzyme normalization. Eat regular meals. Should stabilize within days.

Less Common

•Transient flu-like symptoms

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Severe or worsening side effects that don't improve with dose adjustment or supportive care

×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing

×Your healthcare provider recommends discontinuation based on your clinical response

×Development of any new medical condition that may be contraindicated with Livagen

×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)

×Abnormal lab results or clinical markers that suggest adverse effects

Livagen should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

✓May be used together under medical guidance.

With medications

!Opioid medications (Livagen inhibits enkephalinase with IC50 of 20 μM, potentially prolonging endogenous opioid activity) - Use with caution—discuss with your healthcare provider.

!Immunosuppressive drugs without medical supervision — chromatin reactivation may enhance immune gene expression - Use with caution—discuss with your healthcare provider.

!Other potent peptidase inhibitors — potential for additive effects on enzyme inhibition - Use with caution—discuss with your healthcare provider.

With supplements

✓Multivitamins - Generally safe to take alongside Livagen. Space doses apart if taking oral formulations to ensure optimal absorption.

✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Livagen research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.